A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
Recruiting · NCT06717113 · Registry updated 2025-06-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Early phase 1 | 2025-06-06 | NCT06717113 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University First Hospital | 225 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Nuclear Medicine, Peking University First Hospital | Beijing | China | 1 |
| Peking University First Hospital | Beijing | China | 13 |